The Immediate and Long-term Impacts of the COVID-19 Pandemic on Patients with Obsessive-compulsive Disorder: A One-year Follow-up Study
Overview
Affiliations
Several recent publications have revealed that obsessive-compulsive disorder (OCD) patients were adversely affected during coronavirus disease 2019 (COVID-19); however, how long this negative impact will last is unclear. Our study aimed to investigate the impact of the COVID-19 pandemic on OCD patients after one year. Online questionnaires were administered, and clinical interviews were conducted to assess OCD symptoms, depression, anxiety, information about COVID-19 and mental resilience at baseline (1 December 2019-1 January 2020), during early COVID-19 (26 February-25 March 2020) and at the one-year follow-up (26 February-25 March 2021). A total of 110 OCD patients were enrolled. Our findings showed that OCD, depressive and anxiety symptoms worsened during early COVID-19, and the negative impact persisted at the one-year follow-up. Multivariate analysis showed that female gender, concern about COVID-19 and OCD symptom severity at baseline were risk factors for exacerbation of OCD symptoms during early COVID-19, while optimism, as one composite factor of resilience, was a protective factor against exacerbation of OCD symptoms both during early COVID-19 and at follow-up. Our study showed that COVID-19 had immediate and long-term impacts on the exacerbation of OCD symptoms, and interventions targeted at improving resilience are recommended.
The long-term impact of the covid-19 pandemic on patients with obsessive-compulsive disorder.
Ucar Bostan B, Aksoy Poyraz C, Kara Esen B, Usta Saglam N Medicine (Baltimore). 2025; 104(7):e41562.
PMID: 39960939 PMC: 11835065. DOI: 10.1097/MD.0000000000041562.
Pugi D, Angelo N, Ragucci F, Garcia-Hernandez M, Rosa-Alcazar A, Pozza A Clin Neuropsychiatry. 2023; 20(4):293-308.
PMID: 37791089 PMC: 10544256. DOI: 10.36131/cnfioritieditore20230409.
Severity and Changes in OCD Dimensions during COVID-19: A Two-Year Longitudinal Study.
Rosa-Alcazar A, Parada-Navas J, Garcia-Hernandez M, Pozza A, Tondi P, Rosa-Alcazar A Brain Sci. 2023; 13(8).
PMID: 37626507 PMC: 10452262. DOI: 10.3390/brainsci13081151.
Impact of the COVID-19 pandemic on obsessive-compulsive symptoms in the Swiss general population.
Otte J, Schicktanz N, Bentz D Front Psychol. 2023; 14:1071205.
PMID: 37408969 PMC: 10318181. DOI: 10.3389/fpsyg.2023.1071205.
Shafighi A, Atashzadeh-Shoorideh F, Ebadi A, Ghadirian F BMC Psychiatry. 2023; 23(1):310.
PMID: 37138256 PMC: 10155131. DOI: 10.1186/s12888-023-04762-4.